Swiss Rockets & Squirro Partner to Accelerate AI in Biotechnology
Swiss Rockets AG, a Basel-based biotechnology incubator and accelerator, and Squirro AG, a leading Swiss enterprise AI company, today announced a strategic partnership agreement to drive the AI transformation of Swiss Rockets. The collaboration will introduce Squirro’s Generative AI Platform as the backbone of Swiss Rockets’ digital knowledge ecosystem, supporting the...
The post Swiss Rockets & Squirro Partner to Accelerate AI in Biotechnology first appeared on AI-Tech Park.
Tevogen Expands PredicTcell Data 100x to Boost T Cell Therapies
Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced significant progress in the development of its proprietary PredicTcell™ platform, designed to accelerate precision immunotherapy development and efficacy through advanced machine learning and transformer-based models. The platform is being developed with the support of Microsoft (Nasdaq: MSFT) and Databricks, leveraging their advanced...
The post Tevogen Expands PredicTcell Data 100x to Boost T Cell Therapies first appeared on AI-Tech Park.